Axillary Reverse Mapping

PROCEDURE5 trials

Sponsors

University of Arkansas, M.D. Anderson Cancer Center, Zagazig University, Case Comprehensive Cancer Center, Hospital Universitari de Bellvitge

Conditions

Arm LymphedemaBreast CancerCancer of the BreastEarly Breast CancerLymphatic Spread of Breast CancerLymphedema ArmNode-positive Breast Cancer

Phase 1

Axillary Reverse Mapping for Invasive Carcinoma of the Breast

CompletedNCT00645541

M.D. Anderson Cancer CenterBreast Cancer

Start: 2008-03-31End: 2010-11-30Updated: 2012-08-02

Phase 2

Axillary Reverse Mapping

Active, not recruitingNCT00572481

University of ArkansasCancer of the Breast

Start: 2007-05-31End: 2027-11-30Target: 1000Updated: 2025-11-06

Unknown Phase

Axillary Reverse Mapping Using Methylene Blue Subcutaneous Injection Can Identify Arm Lymph Nodes and Vessels, Measuring Arm Size for Lymphedema, Histopathological Examination of Arm Lymph Nodes Included With Axillary Lymph Node Dissection

CompletedNCT04137744

Zagazig UniversityArm Lymphedema, Early Breast Cancer, Lymphatic Spread of Breast Cancer

Start: 2015-02-28End: 2019-08-31Updated: 2019-11-06

Axillary Node Dissection w or w/o LVB in Node Positive Breast Cancer Patients

Not yet recruitingNCT05970107

Case Comprehensive Cancer CenterNode-positive Breast Cancer

Start: 2026-06-01End: 2028-12-01Target: 400Updated: 2026-02-19

Impact of the ARM Technique on the Prevention of Lymphedema After Axillary Lymphadenectomy: A Multicenter Randomized Clinical Trial

Active, not recruitingNCT07515300

Hospital Universitari de BellvitgeBreast Cancer, Lymphedema Arm

Start: 2026-03-01End: 2028-04-01Target: 100Updated: 2026-04-07